Toon 1 - 5 resultaten van 5 Voor zoekopdracht 'Vibhuti Vyas (15055988)', zoektijd: 0,01s Verfijn jouw resultaten
  1. 1
    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... door Ibrahim Aldoss (15055961)

    Gepubliceerd in 2025
    Andere auteurs:
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... door Ibrahim Aldoss (15055961)

    Gepubliceerd in 2025
    Andere auteurs:
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... door Ibrahim Aldoss (15055961)

    Gepubliceerd in 2025
    Andere auteurs:
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... door Ibrahim Aldoss (15055961)

    Gepubliceerd in 2025
    Andere auteurs:
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... door Ibrahim Aldoss (15055961)

    Gepubliceerd in 2025
    Andere auteurs:
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: